WHO ICTRP trial
Phase II clinical trial of personalized peptide vaccination for standard therapy…
JPRN-UMIN000003590 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000003590 |
|---|---|
| Public title | Phase II clinical trial of personalized peptide vaccination for standard therapy failed liver cancer patients. (except HCV positive patients in stage IV) |
| Scientific title | Phase II clinical trial of personalized peptide vaccination for standard therapy failed liver cancer patients. (except HCV positive patients in stage IV) - Randomized Phase II study of peptide vaccination for liver cancer. |
| Primary sponsor | Kurume University Cancer Vaccine Center |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | liver cancer |
| Interventions | (1st treatment: total 6 times, every weeks) Day 1: Select peptide candidates (up to 4), to which peptide-specific IgGs are detected before vaccination, and administer peptides that showed the highest reactivity. Individually emulsify these… |
| Registration date | Oct 5, 2010 |
| Target size | 100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: